Very high levels of serum GDF15 were also observed in patients with congenital dyserythropoietic anemia type 1 (CDA I) suggesting that GDF15 contributes to the inappropriate suppression of hepcidin with subsequent secondary hemochromatosis in these patients [66, 92]. Here, HAMP is linked to congenital dyserythropoietic anemia type 1.